News

Press Release

2024 2023 2022 2021 2020 2019 2018 2017

The IND Application of Mabwell Innovative Drug 8MW2311 for Injection was Accepted by NMPA

Through New Chapter | Industry Big Names Discuss the Rheumatism Immunity Disease Webinar

Facilitate Development and Accelerate Progress│SHEITC Visit Mabwell to Research and Guide Work

Good News | Mabwell is Officially Listed on the Shanghai Stock Exchange STAR Market

Previous 1 2 3